I am Associate Professor in the Department of Biological Sciences. My research focuses on the characterization of of Mycobacterium tuberculosis.

• COURI Spring 2016 Symposium Mentoring Award - UTEP (04/20/2016)
• Invited speaker at the ASM Rio Grande Branch Annual Meeting - ASM Rio Grande Branch (04/01/2016)
• Invited panelist at the ASBMB Grant Writing Workshop for Early Career Faculty - ASBMB (06/01/2015-06/30/2015)
• COURI Spring 2015 Symposium Mentoring Award - UTEP (04/20/2015)
• 2014 Minority Health and Health Disparities Grantees Conference (12/01/2014)
• 2014 Annual Biomedical Research Conference for Minority Students - ABRCMS (11/15/2014)
• 2nd Annual Infectious Diseases Symposium Texas Tech University Health Science Center El Paso - TexasTech University Health Sciences Center El Paso (11/05/2014)
• Symposium for Biomedical Research - UTEP (11/01/2013)
• ASBMB Grant Writing Workshop for Early Career Faculty travel Award - ASBMB (06/27/2013)
• Guest speaker at EPCC (06/07/2013)
• Sigma Xi member (04/07/2013)
• 3rd Texas Tuberculosis Research Symposium - UTHSC San Antonio (04/05/2013)
• 13th RCMI International Symposium on Health Disparities Travel Award - RCMI (12/12/2012)

• Ph D in Biochemistry, Laval University (2008)
• BS in Biochemistry, Laval University (1995)

• Nα-Acetylation of the virulence factor EsxA is required for mycobacterial cytosolic translocation and virulence Journal of Biological Chemistry 295 17 (2020), Javier Aguilera, Chitra B. Karki, Lin Li, Salvador Vazquez Reyes, Igor Estevao, Brian I. Grajeda, Qi Zhang, Chenoa D. Arico, Hugues Ouellet, Jianjun Sun.
• Nα-Acetylation of the virulence factor EsxA is required for mycobacterial cytosolic translocation and virulence Journal of Biological Chemistry 295 17 (2020), Javier Aguliera, Chitra Karki, Lin Li, Salvador Vasquez-Reyes, Igor Estavo, Brian Grajeda, Qi Zhang, Chenoa D. Arico, Hugues Ouellet, Jianjun Sun.
• N$\alpha$-Acetylation of the virulence factor EsxA is required for mycobacterial cytosolic translocation and virulence Journal of Biological Chemistry 295 17 (2020), Javier Aguilera, Chitra B. Karki, Lin Li, Salvador V. Reyes, Igor Estevao, Brian I. Grajeda, Qi Zhang, Chenoa D. Arico, Hugues Ouellet, Jianjun Sun.
• Regulatory mechanisms of the cholesterol catabolism repressor KstR in Mycobacterium tuberculosis The FASEB Journal (in press), Chenoa D. Arico, Larissa Podust, Hans-Joachim Knölker, Hugues Ouellet.
• Deciphering the mechanism of action of cholesterol analogs as inhibitors of Mycobacterium tuberculosis The FASEB Journal 33 1\_supplement (2019), Miguel A. Carrillo-Alvarado, Andrew Pardo, Laila Alsaihati, Juan C. Noveron, Hugues Ouellet.

• Development of the prairie vole an alternative small rodent model to study Mycobacterium tuberculosis infection (2023), Volume El Paso, Stephanie Kehl, Allison Bauman, Samuel Castillo, Bruce Cushing, Brendan Podell, Gregory Robertson, Hugues Ouellet.
• Elucidating the role of the “essential” cytochrome P450 CYP121 of Mycobacterium tuberculosis (2023), Volume El Paso, Nicole Jones, Hugues Ouellet.
• Establishment of a prairie vole (Microtus ochrogaster) SARS-CoV-2 infection and transmission model (2023), Volume El Paso, Stephanie Kehl, Samuel Castillo, Carlos Valenzuela, Marc B. Cox, Bruce Cushing, Manuel Llano, Hugues Ouellet.
• Development of the prairie vole an alternative small rodent model to study Mycobacterium tuberculosis infection (2023), Volume San Antonio, TX, Stephanie Stephanie, Allison Bauman, Samuel Castillo, Bruce Cushing, Brendan Podell, Gregory Robertson, Hugues Ouellet.
• Elucidating the role of the “essential” cytochrome P450 CYP121 of Mycobacterium tuberculosis (2023), Volume San Antonio, Nicole Jones, Hugues Ouellet.
• Intranasal STING-formulated nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis (2023), Volume San Antonio TX, Samiur Rahman Sefat, Monish Kumar, Stephanie Kehl, Ankita Leekha, Melisa Martinez Peniagua, Nicole Jones, Charles Spencer, Hugues Ouellet, Navin Varadarajan.
• Expression and purification of SARS-CoV-2 S glycoprotein for epitope mapping studies and development of monoclonal antibodies (2022), Volume El Paso, TX, Stephanie Kehl, Hugues Ouellet, Manuel Llano.
• Analysis of the antibody response against SARS-CoV-2 in COVID-19 convalescent and vaccinated individuals (2022), Volume El Paso, TX, Christiancell Salazar, Michelle Pineda, sergio Saucedo, Stephanie Kehl, Hugues Ouellet, Manuel Llano.
• Establishment of a prairie vole (Microtus ochrogaster) SARS-CoV-2 infection and transmission model (2022), Volume El Paso, TX, Stephanie Kehl, Manuel Llano, Hugues Ouellet.
• Establishment of a prairie vole (Microtus ochrogaster) SARS-CoV-2 infection and transmission model (2022), Volume El Paso, Stephanie Kehl, Hugues Ouellet.
• Role of Rv2275-Cyp121 in the pathogenesis of Mycobacterium tuberculosis (2022), Volume El Paso, Nicole Jones, Hugues Ouellet.
• Protection from oxidative-mediated stress on biofilm formation by M. tuberculosis Hemoglobin O (2021), Volume UTEP, Mitali Bhakta, Stephanie Kehl, Hugues Ouellet.
• Cellular and Molecular Tools for Investigating SARS-CoV-2 Infection (2021), Volume UTEP, Hugues Ouellet.
• Role of Rv2275 and Cyp121 in the pathogenesis of M. tuberculosis (2021), Volume El Paso, Nicole I. Jones, Stephanie Kehl, Hugues Ouellet.
• Cholesterol Catabolism in Mycobacterium tuberculosis (2020), Volume Buffalo, Hugues Ouellet.
• Cellular and Molecular Tools for Investigating SARS-CoV-2 Infection (2020), Volume Online, Manuel Llano, Hugues Ouellet.
• Role of FadE28 and FadE29 in the metabolism of cholesterol and PDIM in Mycobacterium tuberculosis (2019), Volume UTEP, Hugues Ouellet, Natalia Becerra.
• Dual role of fadD19 in the metabolism of cholesterol and PDIM in Mycobacterium tuberculosis (2019), Volume UTEP, Hugues Ouellet, Carolina Basurto de Santiago.
• Mechanisms of action of cholesterol analogs as inhibitors of Mycobacterium tuberculosis (2019), Volume UTEP, Julian Perez, Miguel Garza, Miguel Carrillo-Alvarado, Andrew Pardo, Laila Alsaihaiti, Jericho Tipo, Juan C. Noveron, Hugues Ouellet.
• Effector Ligands for the Cholesterol Degradation Repressor KstR in Mycobacterium tuberculosis (2019), Volume Socorro, New Mexico, Hugues Ouellet, Chenoa D. Arico.
• Role of FadE28 and FadE29 in the metabolism of cholesterol and PDIM in Mycobacterium tuberculosis (2019), Volume Socorro, New Mexico, Natalia Becerra, Chenoa D. Arico, Cesar Moreno, Cameron Ellis, Arturo Ortega, Hugues Ouellet.
• Roles of FadD19 in cholesterol catabolism and cell wall biogenesis (2019), Volume Socorro, New Mexico, Jerricho Tipo, Chenoa D. Arico, Cesar Moreno, Hugues Ouellet.
• Targeting the cholesterol catabolic pathway of Mycobacterium tuberculosis using cholesterol analogs (2019), Volume Socorro, New Mexico, Miguel Carrillo-Alvarado, Andrew Pardo, Laila Alsaihaiti, Juan C. Noveron, Hugues Ouellet.
• Deciphering the mechanism of action of cholesterol analogs as inhibitors of Mycobacterium tuberculosis (2019), Volume Orlando, FL, Miguel Carrilo-Alvarado, Andrew Pardo, Laila Alsaihaiti, Juan C. Noveron, Hugues Ouellet.

• Analysis of the antibody response against SARS-CoV-2 in COVID-19 convalescent and vaccinated individuals
• Analysis of the antibody response against SARS-CoV-2 in COVID-19 convalescent and vaccinated individuals